Quality & Regulatory Consulting
Remediation & CAPA Support
Expert support for quality system remediation following regulatory inspection findings, warning letters and non-conformances, from root cause analysis and CAPA development through to regulatory response and effectiveness verification.
Executive Overview
Regulatory inspection findings, whether FDA Form 483 observations, EMA inspection outcome letters or MHRA Deficiency Reports, require prompt, thorough and well-evidenced corrective action responses. The quality of an organisation's CAPA response to inspection findings is itself assessed by regulatory authorities. A CAPA that addresses symptoms rather than root causes, commits to actions that are not implemented or fails to demonstrate systemic improvement is unlikely to satisfy the inspecting authority.
Effective remediation requires both the expertise to identify genuine root causes and the organisational capability to implement sustainable corrective actions. Many quality teams are closest to the systems they are remediating, which limits their ability to objectively assess root causes and the structural changes required to prevent recurrence. Independent remediation support provides the objectivity that internal teams cannot reliably provide under regulatory pressure.
Sthira Assure remediation and CAPA support services cover the full lifecycle of regulatory response, from initial assessment of inspection findings and systematic root cause investigation through CAPA development, implementation oversight, effectiveness verification and preparation of regulatory authority responses. We have supported organisations through significant quality system rebuilding programmes following major inspection findings.
When To Engage
- FDA Warning Letter received
- Form 483 observations issued
- EMA inspection deficiency report
- MHRA GMP/GDP deficiency letter
- Repeat internal audit findings
- Major quality event or recall
- Consent decree or regulatory action
Facing a Regulatory Observation?
The timeline for regulatory responses is tight. Contact us now.
Get in TouchCommon Compliance Risks
Superficial Root Cause Analysis
The single most common reason CAPA responses fail to satisfy regulatory authorities is that they address immediate symptoms rather than the systemic root cause. Inspectors expect structured root cause methodology — Fishbone, 5-Why, FMEA — and corrective actions that would prevent recurrence across all similar processes, not just the specific instance cited. CAPA programmes that close findings without genuine root cause remediation generate repeat findings at the next inspection.
Inadequate CAPA Effectiveness Verification
Regulatory authorities assess not only whether CAPAs have been implemented but whether they have been effective. Organisations that close CAPAs without defined, measurable effectiveness criteria and without documented verification that improvement has been sustained fail a critical component of quality system oversight. Effectiveness verification must be planned at CAPA inception, not added retrospectively.
Unrealistic Response Timelines
Regulatory response commitments that cannot be met damage credibility with inspecting authorities. A CAPA response that commits to systemic remediation within 30 days, when the scope of remediation clearly requires six months, signals that the organisation has not genuinely assessed the problem. Regulators prefer conservative, realistic commitments met on time over optimistic commitments that slip.
Scope Limitation to the Cited Example
When an inspection finding cites a specific example, the expectation is not that the organisation will fix only that example. Regulators expect organisations to assess the systemic risk — whether the same failure mode exists in other products, sites, systems or processes — and to address that broader risk in the CAPA response. Responses that address only the cited example are consistently characterised as inadequate.
Scope of Services
Remediation Services
Root Cause Analysis
Systematic root cause investigation using structured methodologies, Fishbone, 5-Why, FMEA, to identify the underlying causes of quality system failures rather than addressing surface symptoms.
CAPA Development
Development of corrective and preventive action plans that address identified root causes, with defined implementation timelines, responsible owners and measurable effectiveness criteria.
Regulatory Response Support
Support for preparation of responses to FDA warning letters, Form 483 observations, EMA and MHRA inspection findings and other regulatory authority communications requiring corrective action commitments.
CAPA Effectiveness Verification
Independent assessment of implemented CAPAs to verify that actions taken have addressed root causes and that quality system performance has improved as a result. Provides objective evidence of CAPA effectiveness for regulatory submissions.
Quality System Rebuilding
Comprehensive quality system remediation following significant inspection findings, from quality manual and SOP revision through system process redesign, training programme overhaul and KPI framework implementation.
Regulatory Commitment Management
Structured management of regulatory commitments arising from inspection findings, tracking implementation milestones, verifying completion of committed actions and preparing evidence packages for regulatory authority review.
Typical Deliverables
Frequently Asked Questions
How long do we have to respond to FDA Form 483 observations?
There is no regulatory deadline for responding to FDA Form 483 observations, but the FDA expects a written response within 15 business days of the inspection close-out. Responses received after this period may not be considered in the initial FDA classification decision. The response should address each observation with a root cause, proposed corrective actions and a realistic implementation timeline. For Warning Letters, FDA typically expects a response within 15 working days of receipt.
What makes a CAPA response inadequate from a regulator's perspective?
Regulatory authorities consistently find CAPA responses inadequate when they address the immediate symptom rather than the root cause, commit to actions that are not specific, measurable or time-bound, lack provisions for assessing whether the corrective action has been effective, apply corrections only to the specific example cited rather than addressing systemic risk, or are submitted with unrealistic timelines that the organisation then fails to meet. A high-quality CAPA response demonstrates systematic root cause analysis, organisation-wide corrective actions where appropriate and a credible effectiveness verification plan.
Can you help with quality system rebuilding following a consent decree?
Yes. Consent decree compliance requires comprehensive quality system remediation under regulatory authority oversight, with regular reporting of progress against committed milestones. We support organisations in designing remediation programmes that meet consent decree requirements, developing the evidence packages required to demonstrate compliance to FDA, and managing the programme documentation needed to support inspections and milestone reviews.
What does CAPA effectiveness verification involve?
CAPA effectiveness verification confirms that the corrective actions implemented have addressed the root cause and that the problem has not recurred. Verification typically involves reviewing whether committed actions have been completed as described, assessing whether quality metrics that reflect the risk area show improvement, conducting targeted review of the affected system or process and documenting the verification outcome and basis for closure. Regulatory authorities assess CAPA effectiveness as part of repeat inspections.
Get Support with Remediation
Contact our team immediately to discuss your inspection findings, regulatory timeline and remediation approach.